Novel, Submicron Particle, Lower-Dose Diclofenac Demonstrated Relief of Acute Pain in Phase 3 Study –

Iroko to Present Pivotal Data of an Investigational Drug as Late-Breaker at American Headache Society Meeting PHILADELPHIA, June 21, 2012 — Iroko Pharmaceuticals, LLC today announced Phase 3 study results that showed patients treated with the …

Leave a Reply

Your email address will not be published.